Adagrasib Generic NSCLC Drug for G12C Inhibition

Adagrasib is a special kind of medicine that zeroes in on the KRAS G12C mutations in NSCLC, which is also called non-small cell lung cancer. So, this med does its thing by keeping the bad KRAS protein in the cancer cells from sending out the signals that make tumors grow and spread. Adagrasib is available as 200 mg pills, and the usual dose is 600 mg, which you take two times a day.

That means you need to take three of those 200 mg pills every day. And it doesn’t matter if you take it with or without food, it’s pretty flexible. To make it easy to keep track, adagrasib comes in bottles with 180 tablets.

The good thing about it is, it’s strong stuff and you only need to take it once a day, making it easier to manage and stick with the treatment.